<--- Back to Details
First PageDocument Content
Neuroendocrinology / Histiocytosis / Rare diseases / Syndromes / Diabetes insipidus / Nephrology / Desmopressin / Neurogenic diabetes insipidus / Vasopressin / Medicine / Health / Endocrinology
Date: 2014-06-13 09:50:20
Neuroendocrinology
Histiocytosis
Rare diseases
Syndromes
Diabetes insipidus
Nephrology
Desmopressin
Neurogenic diabetes insipidus
Vasopressin
Medicine
Health
Endocrinology

Summary of ECD Global Alliance Internet Chat 26th April[removed]Attendees  There were at least 3 members on the Chat who were on V, and all three said that it was doing

Add to Reading List

Source URL: www.erdheim-chester.org

Download Document from Source Website

File Size: 123,69 KB

Share Document on Facebook

Similar Documents

Instructions for patient on Desmopressin treatment for Diabetes Insipidus Patients are instructed to follow the given guidelines: 1. Never change dosage of medicine without the advise of doctor.

Instructions for patient on Desmopressin treatment for Diabetes Insipidus Patients are instructed to follow the given guidelines: 1. Never change dosage of medicine without the advise of doctor.

DocID: 1ePd1 - View Document

Microsoft Word - Copy of FINAL Proof reader plus NBAdoc

Microsoft Word - Copy of FINAL Proof reader plus NBAdoc

DocID: 18OTt - View Document

doi:j.jfms

doi:j.jfms

DocID: 18ujE - View Document

Microsoft Word - INHIBITOR GUIDELINES.DOC

Microsoft Word - INHIBITOR GUIDELINES.DOC

DocID: 181W0 - View Document

Application for inclusion of a medicine in the WHO Model List of Essential Medicines 1. Summary statement of the proposal for inclusion, change or deletion Inclusion of desmopressin (DDAVP) for the treatment of select pa

Application for inclusion of a medicine in the WHO Model List of Essential Medicines 1. Summary statement of the proposal for inclusion, change or deletion Inclusion of desmopressin (DDAVP) for the treatment of select pa

DocID: 17HrA - View Document